MapLight Therapeutics Inc. is adopting a rarely-used tactic to allow it to go public later this month, even as the US government shutdown prompts other companies seeking initial public offerings to hold off.
Trending
- Analyst Report: Visa Inc
- Coinbase (COIN) Tops Expectations as Transaction Revenue Hits $1B
- Eli Lilly (LLY) earnings Q3 2025
- Apple Earnings Updates: iPhone 17 Demand, AI Progress in Focus
- Silver’s $50 Moment
- Best and Worst Housing Markets of 2026
- Medicare Advantage Could Save You Money—If You’re Willing to Sacrifice This
- Schrodinger Portfolio Update: 28 October 2025

